(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1METHYL-1H-PYRAZOLE-4-CARBOXAMIDE

( DrugBank: Pyrazole, 1H-pyrazole / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
58	肥大型心筋症	2

58. 肥大型心筋症

臨床試験数 : 126 / 薬物数 : 135 - (DrugBank : 42) / 標的遺伝子数 : 46 - 標的パスウェイ数 : 162

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-003571-17-IT (EUCTR)	30/11/2021	02/09/2021	An Open-Label Study of CK3773274 for Patients with Symptomatic Hypertrophic Cardiomyopathy (HCM) an ...	An Open-Label Study of CK3773274 for Patients with Symptomatic Hypertrophic Cardiomyopathy (HCM) an ...	Obstructive Hypertrophic Cardiomyopathy (oHCM) MedDRA version: 20.0;Level: PT;Classification code 10 ...	Product Name: n/a Product Code: [CK-3773274] INN or Proposed INN: CK-3773274 Other descriptive name: (R ...	CYTOKINETICS, INC.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	54	Phase 2	United States;Spain;Italy
2	EUCTR2019-002785-12-IT (EUCTR)	31/03/2020	04/02/2021	Pharmacokinetic and Pharmacodynamic study to evaluate the effect of CK3773274 in patients with obstr ...	A multi-center, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the saf ...	Obstructive hypertrophic cardiomyopathy (oHCM) MedDRA version: 20.0;Level: PT;Classification code 10 ...	Product Name: n/a Product Code: [CK-3773274] INN or Proposed INN: CK-3773274 Other descriptive name: (R ...	CYTOKINETICS, INC.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 2	United States;Spain;Netherlands;United Kingdom;Italy

First Previous1Next Last